Cost Effectiveness in Low- and Middle-Income CountriesA Review of the Debates Surrounding Decision Rules

被引:0
|
作者
Samuel D. Shillcutt
Damian G. Walker
Catherine A. Goodman
Anne J. Mills
机构
[1] Johns Hopkins Bloomberg School of Public Health,Department of International Health
[2] Kenya Medical Research Institute/Wellcome Trust Research Programme,Department of Public Health & Policy
[3] London School of Hygiene & Tropical Medicine,undefined
来源
PharmacoEconomics | 2009年 / 27卷
关键词
Contingent Valuation; Health Gain; Gross National Income; Preference Elicitation; Human Capital Approach;
D O I
暂无
中图分类号
学科分类号
摘要
Cost-effectiveness analysis (CEA) is increasingly important in public health decision making, including in low- and middle-income countries. The decision makers’ valuation of a unit of health gain, or ceiling ratio (λ), is important in CEA as the relative value against which acceptability is defined, although values are usually chosen arbitrarily in practice. Reference case estimates for λ are useful to promote consistency, facilitate new developments in decision analysis, compare estimates against benefit-cost ratios from other economic sectors, and explicitly inform decisions about equity in global health budgets.
引用
收藏
页码:903 / 917
页数:14
相关论文
共 50 条
  • [21] The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature
    Debellut, Frederic
    Friedrich, Alena
    Baral, Ranju
    Pecenka, Clint
    Mugisha, Emmanuel
    Neuzil, Kathleen M.
    PLOS ONE, 2024, 19 (06):
  • [22] Cost of illness of breast cancer in low- and middle-income countries: a systematic review
    Yeong, Siew Wei
    Lee, Sit Wai
    Ong, Siew Chin
    HEALTH ECONOMICS REVIEW, 2024, 14 (01):
  • [23] Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries
    Linde, Mattias
    Steiner, Timothy J.
    Chisholm, Dan
    JOURNAL OF HEADACHE AND PAIN, 2015, 16
  • [24] Cost-effectiveness of Coronavirus Disease 2019 Vaccination in Low- and Middle-Income Countries
    Siedner, Mark J.
    Alba, Christopher
    Fitzmaurice, Kieran P.
    Gilbert, Rebecca F.
    Scott, Justine A.
    Shebl, Fatma M.
    Ciaranello, Andrea
    Reddy, Krishna P.
    Freedberg, Kenneth A.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (11): : 1887 - 1896
  • [25] Cost-effectiveness analyses for injury prevention initiatives in low- and middle-income countries
    Scuffham, Paul A.
    INJURY PREVENTION, 2008, 14 (04) : 217 - 219
  • [26] Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
    Knight, Gwenan M.
    Griffiths, Ulla K.
    Sumner, Tom
    Laurence, Yoko V.
    Gheorghe, Adrian
    Vassall, Anna
    Glaziou, Philippe
    White, Richard G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (43) : 15520 - 15525
  • [27] Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
    Horton, Susan
    Gelband, Hellen
    Jamison, Dean
    Levin, Carol
    Nugent, Rachel
    Watkins, David
    PLOS ONE, 2017, 12 (08):
  • [28] The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries
    Razavi, Homie
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (02) : 445 - 445
  • [29] Financing and cost-effectiveness of emergency medical services in low- and middle-income countries
    Delaney, Peter G.
    Offorjebe, Agatha
    Arudo, John
    SURGERY, 2024, 176 (04) : 1302 - 1304
  • [30] Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries
    Mattias Linde
    Timothy J Steiner
    Dan Chisholm
    The Journal of Headache and Pain, 2015, 16